0001209191-22-003188.txt : 20220113
0001209191-22-003188.hdr.sgml : 20220113
20220113162820
ACCESSION NUMBER: 0001209191-22-003188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220113
DATE AS OF CHANGE: 20220113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freeman Mason
CENTRAL INDEX KEY: 0001745948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41201
FILM NUMBER: 22529333
MAIL ADDRESS:
STREET 1: C/O CRINETICS PHARMACEUTICALS, INC.
STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CinCor Pharma, Inc.
CENTRAL INDEX KEY: 0001868734
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 8445311834
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-11
0
0001868734
CinCor Pharma, Inc.
CINC
0001745948
Freeman Mason
C/O CINCOR PHARMA, INC
200 CLARENDON STREET, 6TH FLOOR
BOSTON
MA
02116
0
1
0
0
EVP Clinical Development
Common Stock
2022-01-11
4
P
0
2500
16.00
A
2500
D
Common Stock
2022-01-11
4
P
0
100
16.00
A
100
I
By spouse
The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
/s/ Cathy Rude, Attorney-in-Fact
2022-01-13